Yanal Murad

817 total citations
26 papers, 583 citations indexed

About

Yanal Murad is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Yanal Murad has authored 26 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Oncology and 8 papers in Immunology. Recurrent topics in Yanal Murad's work include Virus-based gene therapy research (11 papers), CAR-T cell therapy research (7 papers) and Immunotherapy and Immune Responses (7 papers). Yanal Murad is often cited by papers focused on Virus-based gene therapy research (11 papers), CAR-T cell therapy research (7 papers) and Immunotherapy and Immune Responses (7 papers). Yanal Murad collaborates with scholars based in Canada, United States and China. Yanal Murad's co-authors include Timothy M. Clay, Tibor T. Glant, Katalin Mikecz, Ronghua Zhao, Jianbing Zhang, H. Kim Lyerly, Michael A. Morse, Edit I. Buzás, Ismael Samudio and István Gál and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Yanal Murad

26 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanal Murad Canada 14 226 209 166 108 106 26 583
Agnes E. Hamburger United States 13 287 1.3× 262 1.3× 156 0.9× 46 0.4× 122 1.2× 19 769
Hanna Dreja United Kingdom 13 399 1.8× 438 2.1× 143 0.9× 197 1.8× 87 0.8× 24 818
Rafael Núñez United States 14 291 1.3× 243 1.2× 124 0.7× 65 0.6× 34 0.3× 40 748
Mili Gu United States 10 294 1.3× 226 1.1× 73 0.4× 135 1.3× 57 0.5× 16 595
Y. Moroi Japan 14 234 1.0× 328 1.6× 135 0.8× 52 0.5× 36 0.3× 22 621
Ussama M. Abdel‐Motal United States 17 341 1.5× 514 2.5× 71 0.4× 179 1.7× 146 1.4× 29 1.0k
Laurent Malherbe United States 19 220 1.0× 1.0k 4.8× 211 1.3× 73 0.7× 104 1.0× 42 1.3k
Andreas Hüser Germany 9 323 1.4× 91 0.4× 60 0.4× 197 1.8× 45 0.4× 11 563
Laura Arribillaga Spain 14 163 0.7× 516 2.5× 175 1.1× 64 0.6× 58 0.5× 22 819
Sungae Cho South Korea 8 260 1.2× 582 2.8× 151 0.9× 194 1.8× 58 0.5× 11 897

Countries citing papers authored by Yanal Murad

Since Specialization
Citations

This map shows the geographic impact of Yanal Murad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanal Murad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanal Murad more than expected).

Fields of papers citing papers by Yanal Murad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanal Murad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanal Murad. The network helps show where Yanal Murad may publish in the future.

Co-authorship network of co-authors of Yanal Murad

This figure shows the co-authorship network connecting the top 25 collaborators of Yanal Murad. A scholar is included among the top collaborators of Yanal Murad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanal Murad. Yanal Murad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Yiting, et al.. (2024). Oncolytic virotherapy stimulates anti‑tumor immune response and demonstrates activity in advanced sarcoma: Report of two cases. Oncology Letters. 27(6). 244–244. 1 indexed citations
2.
3.
Fu, Siqing, Madappa N. Kundranda, Yinan Shen, et al.. (2023). The initial report of phase I trial of VG2025, a non-attenuated HSV-1 oncolytic virus expressing IL-12 and IL-15/RA payloads, in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 2580–2580. 2 indexed citations
4.
Murad, Yanal, I‐Fang Lee, Guoyu Liu, et al.. (2023). Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1. Molecular Therapy — Oncolytics. 28. 334–348. 11 indexed citations
5.
Murad, Yanal, Jiang Xu, Yingying Song, et al.. (2023). mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge. Nature Communications. 14(1). 5925–5925. 70 indexed citations
6.
Shen, Yinan, Wei Song, Danni Lin, et al.. (2022). VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes. Journal of Medical Virology. 95(1). e28108–e28108. 19 indexed citations
7.
Murad, Yanal, Guoyu Liu, Yi Sun, et al.. (2020). Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes. Biomedicines. 8(11). 484–484. 43 indexed citations
8.
Murad, Yanal, et al.. (2016). False Negative Results in Clostridium difficile Testing. BMC Infectious Diseases. 16(1). 430–430. 15 indexed citations
9.
Bhardwaj, Nitin, Nelson F. Eng, Yanal Murad, et al.. (2016). Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1). Heliyon. 2(8). e00147–e00147. 9 indexed citations
10.
Murad, Yanal, et al.. (2015). Impact of polymerase chain reaction testing on Clostridium difficile infection rates in an acute health care facility. American Journal of Infection Control. 43(4). 383–386. 13 indexed citations
11.
Agrawal, Vishal, Igor Slivac, Sylvie Perret, et al.. (2012). Stable Expression of Chimeric Heavy Chain Antibodies in CHO Cells. Methods in molecular biology. 911. 287–303. 36 indexed citations
12.
Cheng, Tsai-Mu, Yanal Murad, Chia‐Ching Chang, et al.. (2012). Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells. European Journal of Cancer. 50(4). 713–721. 26 indexed citations
13.
Niu, Gang, Yanal Murad, Haokao Gao, et al.. (2012). Molecular targeting of CEACAM6 using antibody probes of different sizes. Journal of Controlled Release. 161(1). 18–24. 20 indexed citations
14.
Baral, Toya Nath, et al.. (2011). Isolation of functional single domain antibody by whole cell immunization: Implications for cancer treatment. Journal of Immunological Methods. 371(1-2). 70–80. 16 indexed citations
15.
Murad, Yanal & Timothy M. Clay. (2009). CpG Oligodeoxyneucleotides as TLR9 Agonists. BioDrugs. 23(6). 361–375. 88 indexed citations
16.
Murad, Yanal, Timothy M. Clay, H. Kim Lyerly, & Michael A. Morse. (2007). CPG-7909 (PF-3512676, ProMune®): toll-like receptor-9 agonist in cancer therapy. Expert Opinion on Biological Therapy. 7(8). 1257–1266. 44 indexed citations
17.
Buzás, Edit I., Ákos Végvári, Yanal Murad, et al.. (2005). T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis. Cellular Immunology. 235(2). 98–108. 32 indexed citations
18.
Buzás, Edit I., Yanal Murad, Ferenc Hudecz, et al.. (2003). Differential Recognition of Altered Peptide Ligands Distinguishes Two Functionally Discordant (Arthritogenic and Nonarthritogenic) Autoreactive T Cell Hybridoma Clones. The Journal of Immunology. 171(6). 3025–3033. 17 indexed citations
19.
20.
Kot, Eva, Yanal Murad, & Anatoly Bezkorovainy. (2001). The Effect of Nisin on the Physiology of Bifidobacterium thermophilum. Journal of Food Protection. 64(8). 1206–1210. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnes E. Hamburger Breakdown of academic impact, for papers by Hanna Dreja Breakdown of academic impact, for papers by Rafael Núñez Breakdown of academic impact, for papers by Mili Gu Breakdown of academic impact, for papers by Y. Moroi Breakdown of academic impact, for papers by Ussama M. Abdel‐Motal Breakdown of academic impact, for papers by Laurent Malherbe Breakdown of academic impact, for papers by Andreas Hüser Breakdown of academic impact, for papers by Laura Arribillaga Breakdown of academic impact, for papers by Sungae Cho
Rankless by CCL
2026